DE3484329D1 - Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra. - Google Patents

Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra.

Info

Publication number
DE3484329D1
DE3484329D1 DE8484108378T DE3484329T DE3484329D1 DE 3484329 D1 DE3484329 D1 DE 3484329D1 DE 8484108378 T DE8484108378 T DE 8484108378T DE 3484329 T DE3484329 T DE 3484329T DE 3484329 D1 DE3484329 D1 DE 3484329D1
Authority
DE
Germany
Prior art keywords
lepra
treatment
production
active substance
gamma interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484108378T
Other languages
English (en)
Inventor
Nadia Nogueira
Ralph Steinman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24064440&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3484329(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rockefeller University filed Critical Rockefeller University
Application granted granted Critical
Publication of DE3484329D1 publication Critical patent/DE3484329D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE8484108378T 1983-07-29 1984-07-17 Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra. Expired - Fee Related DE3484329D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51855283A 1983-07-29 1983-07-29

Publications (1)

Publication Number Publication Date
DE3484329D1 true DE3484329D1 (de) 1991-05-02

Family

ID=24064440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484108378T Expired - Fee Related DE3484329D1 (de) 1983-07-29 1984-07-17 Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra.

Country Status (4)

Country Link
EP (1) EP0132754B1 (de)
JP (1) JPS6051117A (de)
CA (1) CA1247004A (de)
DE (1) DE3484329D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149551A3 (de) * 1984-01-16 1987-09-23 Genentech, Inc. Synergistische Gamma-Interferon-Interleukin-2-Zusammensetzungen und Verfahren zur Herstellung desselben
DE3779909T2 (de) * 1986-03-06 1993-01-07 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
EP0315300A3 (de) * 1987-11-05 1989-08-02 Takeda Chemical Industries, Ltd. Behandlung von tuberkulösen und nichttuberkulösen mycobakteriellen Infektionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0090837A1 (de) * 1981-10-08 1983-10-12 BERG, Kurt Frimann Verfahren und zusammensetzung zum behandeln von kranken die an interferon empfindlichen krankheiten leiden

Also Published As

Publication number Publication date
CA1247004A (en) 1988-12-20
EP0132754A3 (en) 1988-03-30
JPS6051117A (ja) 1985-03-22
EP0132754A2 (de) 1985-02-13
EP0132754B1 (de) 1991-03-27

Similar Documents

Publication Publication Date Title
FI843496A (fi) Anordning foer att finna tvaergaoende borrhaol i implantat i benmaergen.
DE3586335D1 (de) Herstellung von gamma-interferon.
ATA117983A (de) Fluoridhaltiger gegenstand zur zahnbehandlung und -pflege
DE3880118D1 (de) Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung.
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
ES521401A0 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
IT1057453B (it) Perfezionamento nelle protesi dentarie
AT355726B (de) Verfahren zur herstellung von ihren wirkstoff geregelt abgebenden biologisch aktiven praeparaten
DE3483330D1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
AT344496B (de) Verfahren zur verhinderung von aeroben abbauvorgaengen im gaerfutter und mittel zur durchfuehrung des verfahrens
DE3484329D1 (de) Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra.
CH554896A (de) Verfahren zur herstellung von p-nitrobenzyl-desacetoxycephalosporinestern und deren verwendung.
CH522617A (de) Verfahren zur Herstellung von Thioureidobenzolen sowie deren Verwendung in fungiziden und akariziden Mitteln
AT351666B (de) Einrichtung zur pflege von aerztlichen, insbesondere zahnaerztlichen handstuecken bzw. deren teilen
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
CH550203A (de) Verfahren zur herstellung von in c8-stellung modifizierten purinribofuranosid-3' :5'-cyclophosphaten und deren verwendung.
CH508603A (de) Verfahren zur Herstellung von Amidophenylguanidinen und ihre fungizide Verwendung
DE3486005D1 (de) Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen.
IT1083711B (it) Perfezionamento nei procedimenti per la depurazione disinfezione e neutralizzazione di acque di scarico
IT1091129B (it) Composizione e procedimento per il trattamento di materiali cellulosici
NO147625C (no) Stimuliopploesning til bruk i fiskeagn eller fiskefor
DE3482308D1 (de) Verfahren zur radioaktiven markierung von blutzellen und zusammensetzungen dafuer.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
IT1116883B (it) Perfezionamento nelle protesi per sostituzioni valmolapi cardiache
ATE65398T1 (de) Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee